Can on-demand non-sedating antihistamines improve Urticaria symptoms? A double-blind, randomized, single-dose study

Acta Dermato-Venereologica

Volumn 93, Issue 2, 2013, Pages 168-174

  Weller, Karsten ^a   Ardelean, Elena ^a   Scholz, Elisabeth ^a   Martus, Peter ^b   Zuberbier, Torsten ^a   Maurer, Marcus ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Antihistamines; Clinical trial; Urticaria

Indexed keywords

DESLORATADINE;

ADULT; AGED; ARTICLE; CHRONIC URTICARIA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HUMAN; HYPERTHERMIA; INTERVENTION STUDY; MALE; PRIORITY JOURNAL; PROPHYLAXIS; SINGLE DRUG DOSE; TREATMENT OUTCOME;

ADULT; AGED; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; GERMANY; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HUMANS; LORATADINE; MIDDLE AGED; SKIN; TIME FACTORS; TREATMENT OUTCOME; URTICARIA; YOUNG ADULT;

EID: 84875072005     PISSN: 00015555     EISSN: 16512057     Source Type: Journal    
DOI: 10.2340/00015555-1434     Document Type: Article

References (27)

1. Zuberbier T, Asero R, Bindslev-Jensen C, Walter Canonica G, Church MK, Giménez-Arnau A, et al. EAACI/GA(2) LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy 2009; 64: 1417-1426.
2. Greaves MW. Chronic urticaria. N Engl J Med 1995; 332: 1767-1772.
3. Młynek A, Magerl M, Hanna M, Lhachimi S, Baiardini I, Canonica GW, et al. The German version of the Chronic Urticaria Quality-of-Life Questionnaire: factor analysis, validation, and initial clinical findings. Allergy 2009; 64: 927-936.
4. O'Donnell B, Lawlor F, Simpson J, Morgan M, Greaves M. The impact of chronic urticaria on the quality of life. Br J Dermatol 1997; 136: 197-201.
5. Maurer M, Ortonne J, Zuberbier T. Chronic urticaria: a patient survey on quality-of-life, treatment usage and doctorpatient relation. Allergy 2009; 64: 581-588.
6. Kaplan AP. Chronic urticaria: pathogenesis and treatment. J Allergy Clin Immunol 2004; 114: 465-474.
7. Zuberbier T, Asero R, Bindslev-Jensen C, Walter Canonica G, Church MK, Giménez-Arnau AM, et al. EAACI/GA(2) LEN/EDF/WAO guideline: management of urticaria. Allergy 2009; 64: 1427-1443.
8. Ciprandi G, Passalacqua G, Mincarini M, Ricca V, Canonica GW. Continuous versus on demand treatment with cetirizine for allergic rhinitis. Ann Allergy Asthma Immunol 1997; 79: 507-511.
9. Canonica GW, Fumagalli F, Guerra L, Baiardini I, Compalati E, Rogkakou A, et al. Levocetirizine in persistent allergic rhinitis: continuous or on-demand use? A pilot study. Curr Med Res Opin 2008; 24: 2829-2839.
10. Ciprandi G, Tosca M, Passalacqua G, Canonica GW. Longterm cetirizine treatment reduces allergic symptoms and drug prescriptions in children with mite allergy. Ann Allergy Asthma Immunol 2001; 87: 222-226.
11. Grob J, Auquier P, Dreyfus I, Ortonne J. How to prescribe antihistamines for chronic idiopathic urticaria: desloratadine daily vs PRN and quality of life. Allergy 2009; 64: 605-612.
12. Ring J, Hein R, Gauger A, Bronsky E, Miller B. Once-daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria: a randomized, double-blind, placebocontrolled study. Int J Dermatol 2001; 40: 72-76.
13. Monroe E, Finn A, Patel P, Guerrero R, Ratner P, Bernstein D. Efficacy and safety of desloratadine 5 mg once daily in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial. J Am Acad Dermatol 2003; 48: 535-541.
14. Ortonne J, Grob J, Auquier P, Dreyfus I. Efficacy and safety of desloratadine in adults with chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, multicenter trial. Am J Clin Dermatol 2007; 8: 37-42.
15. Grob JJ, Lachapelle JM. Non-sedating antihistamines in the treatment of chronic idiopathic urticaria using patient-reported outcomes. Curr Med Res Opin 2008; 24: 2423-2428.
16. Bachert C, Maurer M. Safety and efficacy of desloratadine in subjects with seasonal allergic rhinitis or chronic urticaria: results of four postmarketing surveillance studies. Clin Drug Investig 2010; 30: 109-122.
17. DuBuske L. Desloratadine for chronic idiopathic urticaria: a review of clinical efficacy. Am J Clin Dermatol 2007; 8: 271-283.
18. Siebenhaar F, Degener F, Zuberbier T, Martus P, Maurer M. High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study. J Allergy Clin Immunol 2009; 123: 672-679.
19. Staevska M, Popov TA, Kralimarkova T, Lazarova C, Kraeva S, Popova D, et al. The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria. J Allergy Clin Immunol 2010; 125: 676-682.
20. Giménez-Arnau A, Izquierdo I, Maurer M. The use of a responder analysis to identify clinically meaningful differences in chronic urticaria patients following placebocontrolled treatment with rupatadine 10 and 20 mg. J Eur Acad Dermatol Venereol 2009; 23: 1088-1091.
21. Młynek A, Zalewska-Janowska A, Martus P, Staubach P, Zuberbier T, Maurer M. How to assess disease activity in patients with chronic urticaria? Allergy 2008; 63: 777-780.
22. de Weck AL, Derer T, Bischoff SC, Takafuji S. The effect of terfenadine on the immediate and late-phase reactions mediated by immunoglobulin E. Int Arch Allergy Immunol 1993; 101: 326-332.
23. Larbig M, Burtin B, Martin L, Stamm H, Luettig B, Hohlfeld JM, et al. Facial thermography is a sensitive tool to determine antihistaminic activity: comparison of levocetirizine and fexofenadine. Br J Clin Pharmacol 2006; 62: 158-164.
24. dos Santos RV, Magerl M, Mlynek A, Lima HC. Suppression of histamine-and allergen-induced skin reactions: comparison of first-and second-generation antihistamines. Ann Allergy Asthma Immunol 2009; 102: 495-499.
25. 2LEN task force report. Allergy 2011; 66: 317-330.
26. Dizdar EA, Sekerel BE, Keskin O, Kalayci O, Adalioglu G, Dogan C, et al. The effect of regular versus on-demand desloratadine treatment in children with allergic rhinitis. Int J Pediatr Otorhinolaryngol 2007; 71: 843-849.
27. Laekeman G, Simoens S, Buffels J, Gillard M, Robillard T, Benedetti MS, et al. Continuous versus on-demand pharmacotherapy of allergic rhinitis: evidence and practice. Respir Med 2010; 104: 615-625.